
Sign up to save your podcasts
Or


Dr Bill Nelson talks with Dr Matthias Holdhoff about the treatment of brain cancer and a significant FDA approval of a new drug treatment for a type of brain cancer, called low-grade glioma. The drug, called vorasidenib, is a targeted cancer therapy that works by inhibiting the activity of a mutated gene called IDH, slowing the growth of the cancer. Read more here
By Johns Hopkins Kimmel Cancer Center4.6
99 ratings
Dr Bill Nelson talks with Dr Matthias Holdhoff about the treatment of brain cancer and a significant FDA approval of a new drug treatment for a type of brain cancer, called low-grade glioma. The drug, called vorasidenib, is a targeted cancer therapy that works by inhibiting the activity of a mutated gene called IDH, slowing the growth of the cancer. Read more here

32,092 Listeners

40 Listeners

6 Listeners

26 Listeners

820 Listeners

4 Listeners

298 Listeners

112,946 Listeners

56,549 Listeners

324 Listeners

45 Listeners

16 Listeners

2 Listeners

25 Listeners

8,177 Listeners

625 Listeners

57,911 Listeners

156 Listeners

807 Listeners